The Cold Open
MOTS-c has the best story in this whole newsletter. It's a signaling molecule encoded inside your mitochondria, discovered only a decade ago, that spikes in your bloodstream when you exercise. In mice, injecting it reverses obesity, improves insulin sensitivity, and extends physical performance in old age. Clinics sell it as "exercise in a bottle." This month: the fascinating basic science, the gap between mouse and human, and why one observational human study isn't what the marketing implies.
Peptide of the Month: MOTS-c
What it is. MOTS-c is a 16-amino-acid peptide discovered in 2015 at USC. Here's what makes it weird: most peptides are encoded by DNA in your cell's nucleus. MOTS-c is encoded by DNA inside your mitochondria, the tiny energy factories inside each cell. Under stress, MOTS-c travels from the mitochondria to the nucleus and changes gene expression. Think of mitochondria as a power plant that occasionally sends a memo to corporate headquarters. MOTS-c is that memo.
What it's supposedly for. Fat loss, metabolic improvement, endurance boost, bone health, anti-aging. The "exercise mimetic" pitch is that MOTS-c gives you the metabolic benefits of a workout without the workout.
The evidence as of today. The mouse data is striking. A 2015 paper showed MOTS-c prevented diet-induced obesity and reversed age-dependent insulin resistance in mice. A 2021 paper showed it improved physical performance in old mice. A 2018 paper showed it prevented bone loss after ovariectomy. On the human side, there is exactly one published study, and it is observational. The 2021 Nature Communications paper measured natural MOTS-c in healthy young men and found it spiked about 119 percent in skeletal muscle and 50 percent in plasma during cycling. Interesting. Not evidence that injecting MOTS-c does anything therapeutic.
One thing to know: AMPK activation. MOTS-c activates an enzyme called AMPK. AMPK is the cellular switch that turns on when energy is low, telling cells to burn fat and take up glucose. Exercise activates it. Fasting activates it. Metformin activates it. MOTS-c is one more way to hit the same switch.
Thousands of words about exercise mimetics. One observational human study. Zero interventional human trials.
The catch. Not FDA-approved. No human has been injected with synthetic MOTS-c in a peer-reviewed trial and measured for weight loss, insulin sensitivity, or endurance. Every efficacy claim you see is a mouse claim dressed up in human marketing language. The exercise-induced spike data is fascinating basic science. It is not the same as saying "injections work."
Myth Check: "MOTS-c is exercise in a bottle"
The phrase is everywhere. It makes intuitive sense: if exercise makes MOTS-c go up, and MOTS-c does good things, then injecting MOTS-c should replicate exercise benefits.
Except exercise does hundreds of things simultaneously. It increases blood flow, releases irisin, stimulates BDNF, stresses and repairs muscle, trains mitochondria to be more efficient, and activates dozens of signaling pathways in a coordinated sequence. MOTS-c is one thread in that tapestry. Injecting MOTS-c and calling it exercise is like playing one note from a symphony and calling it the concert.
The rule: When a biomarker goes up during exercise, that does not mean injecting the biomarker produces the benefits of exercise. Exercise is the cause. The biomarker is a footprint.
Not medical advice. Most peptides discussed in this newsletter are investigational or research chemicals. Talk to a clinician before starting anything.